Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Cost of dengue cases in eight countries in the Americas and asia: A prospective study
Authors: Jose A. Suaya
Donald S. Shepard
João B. Siqueira
Celina T. Martelli
Lucy C.S. Lum
Lian Huat Tan
Sukhontha Kongsin
Sukhum Jiamton
Fàtima Garrido
Romeo Montoya
Brandeis University
Universidade Federal de Goias
University of Malaya Medical Centre
Mahidol University
Ministry of Health and Social Development
Ministry of Health and Social Assistance
Instituto Conmemorativo Gorgas de Estudios de la Salud
National Center for Malaria Control
National Laboratory of Public Health
International Vaccine Institute, Seoul
University of Malaya
Instituto Conmemorativo Gorgas de Estudio de la Salud de Panamá
Keywords: Immunology and Microbiology;Medicine
Issue Date: 1-May-2009
Citation: American Journal of Tropical Medicine and Hygiene. Vol.80, No.5 (2009), 846-855
Abstract: Despite the growing worldwide burden of dengue fever, the global economic impact of dengue illness is poorly documented. Using a common protocol, we present the first multicountry estimates of the direct and indirect costs of dengue cases in eight American and Asian countries. We conducted prospective studies of the cost of dengue in five countries in the Americas (Brazil, El Salvador, Guatemala, Panama, and Venezuela) and three countries in Asia (Cambodia, Malaysia, and Thailand). All studies followed the same core protocol with interviews and medical record reviews. The study populations were patients treated in ambulatory and hospital settings with a clinical diagnosis of den-gue. Most studies were performed in 2005. Costs are in 2005 international dollars (1$). We studied 1,695 patients (48% pediatric and 52% adult); none died. The average illness lasted 11.9 days for ambulatory patients and 11.0 days for hospi-talized patients. Among hospitalized patients, students lost 5.6 days of school, whereas those working lost 9.9 work days per average dengue episode. Overall mean costs were 1$514 and I$l,394 for an ambulatory and hospitalized case, respec-tively. With an annual average of 574,000 cases reported, the aggregate annual economic cost of dengue for the eight study countries is at least I$587 million. Preliminary adjustment for under-reporting could raise this total to $1.8 billion, and incorporating costs of dengue surveillance and vector control would raise the amount further. Dengue imposes substantial costs on both the health sector and the overall economy. Copyright © 2008 by The American Society of Tropical Medicine and Hygiene.
ISSN: 00029637
Appears in Collections:Scopus 2006-2010

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.